MannKind Jumps After Amazon Prime Takes on One Drop
MannKind Corp. (NASDAQ: MNKD) saw its shares make a massive gain on Monday after it was announced that its One Drop Chrome is now available on Amazon Prime. Overall this is huge of the…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 170
Horizon Pharma Sinks on Missed Earnings and Guidance
Horizon Pharma PLC (NASDAQ: HZNP) saw its shares hit a 52-week low on Monday after the company released its first-quarter financial results. The company said that it had $0.21 in EPS and $220.9 million…
Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated?
Immunomedics watched its shares make a massive gain on Friday after the company announced the termination of its licensing deal with Seattle Genetics.
AmpliPhi Biosciences Crumbles After Announcing Secondary Offering
AmpliPhi Biosciences saw its shares crater on Friday after the company announced that pricing of its secondary offering.
JPMorgan Has 3 Top Pick Large Cap Pharmaceuticals to Buy for the Rest of 2017
JPMorgan has made the case that the best place for investors to look when considering large cap drug stocks is companies that have strong new product cycles already in motion.
Pieris Pharma Soars on AstraZeneca Collaboration
Shares of Pieris Pharmaceuticals saw perhaps one of the biggest gains on Wednesday after the company announced a critical collaboration with AstraZeneca.
Gilead Faces Serious Conundrum: Value Trap vs Real Value
Many value investors have flocked to Gilead Sciences as the world's top biotech stock now that it is valued at a lower multiple than Big Pharma rivals.
Pfizer Sinks on Mixed Q1 Earnings
Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.
Valeant Still Has a Long Way to Go on Paying Down Its Debt
Following the closing of the sale of three skincare brands to L'Oréal and after the closing of the divestiture of a manufacturing facility in Brazil, Valeant said that it now has further reduced its…
Intra-Cellular Therapies Sinks on FDA Update
Intra-Cellular Therapies saw its stock crumble early on Monday after the company provided an update on its plan to submit a New Drug Application for its treatment of schizophrenia.
AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday
24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their earnings on Thursday.
Short Sellers Grow More Selective on Major Biotechs
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Short Sellers Can’t Make Up Their Minds on Major Pharma
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Analysts Try to Defend Express Scripts After Anthem Contract Loss
Express Scripts is among the biggest large cap losers on Wall Street on Tuesday. It's as if the market bounce doesn't even matter.
XBiotech Stock Crumbles Following Disappointing EMA Meeting
XBiotech saw its shares fall sharply after the company issued an update on its recent meeting with the European Medical Agency (EMA).